Former Pakistan prime minister Imran Khan met his party colleague Shah Mehmood Qureshi in Adiala jail during a hearing in connection with the cipher case. Khan has been held in the high-security jail since September 26, following his arrest for allegedly violating the Official Secrets Act. The hearing was adjourned until October 9.
Read MoreTata Steel arm TCIL gets Rs 40 crore tax penalty notice
Read MoreAsmi Adkar failed to capitalise on a match point as she went down fighting to second seed Suhitha Maruri in the Under-18 women’s singles quarterfinals at the Fenesta Open National hard-court tennis championships in New Delhi on Thursday.
Read MoreThe Reserve Bank on Thursday said that as many as 30 banks have been onboarded on the UDGAM (Unclaimed Deposits – Gateway to Access information) portal to enable people to claim and search unclaimed deposits.The RBI on August 17 launched the UDGAM portal to facilitate the public to search their unclaimed deposits across multiple...
Read MoreYou can take Indians out of India, but you can rarely take cricket out of them. When Netherlands open their campaign against Pakistan in Hyderabad on Friday, three key players of the Dutch squad —Teja Nidamanuru, Vikramjit Singh and Aryan Dutt will fulfil their families’ long-standing dream of watching them play a World Cup...
Read MoreNokia has opened a 6G Lab in Bangalore to accelerate the development of 6G technology. The lab will focus on researching “Network as a Sensor” technology, which enables the network to sense objects and movement without on-board sensors. The lab is in line with India’s “Bharat 6G Vision” and aims to establish India as...
Read MoreThe DishaSOS app demonstrated its effectiveness in promptly assisting and safeguarding a distressed foreign student in Visakhapatnam city.
Read MoreCanadian pharmaceutical company, Apotex Inc, is seeking $118.14 million from Panacea Biotec over a breach of a collaboration agreement signed in 2014. Apotex alleges that Panacea Biotec breached its obligations under the agreement, specifically regarding the delay in seeking approval from the US Food and Drug Administration for a product mentioned in the agreement.
Read More